Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
IAC Express
|
2012 Issues
|
Issue 997
IAC Express: Weekly immunization news and information
IAC Express 997: June 5, 2012

TOP STORIES

VACCINE INFORMATION STATEMENTS

OFFICIAL RELEASES AND ANNOUNCEMENTS

FEATURED RESOURCES
JOURNAL ARTICLES AND NEWSLETTERS

EDUCATION AND TRAINING



TOP STORIES

CDC publishes article about FDA licensure of Prevnar 13 (PCV13) for use in adults
CDC published Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older in the June 1 issue of MMWR (pages 394–395). A press summary of the article is reprinted below.

On December 30, 2011, FDA approved 13-valent pneumococcal conjugate vaccine (PCV13) for prevention of pneumonia and invasive disease among adults 50 years and older. The ACIP Pneumococcal Vaccines Work Group reviewed the results of immunogenicity and safety studies conducted to obtain FDA approval and identified two critical gaps in evidence needed to support a recommendation for routine PCV13 use among adults: (1) results from an ongoing clinical trial of PCV13 efficacy against pneumococcal pneumonia, and (2) data that will tell us if use of PCV13 in children also prevents adult disease. At this time, two vaccines for prevention of pneumococcal disease are licensed for adults: 23-valent pneumococcal polysaccharide vaccine (PPSV23) and PCV13. ACIP recommendations for PPSV23 use remain unchanged. PCV13, although not yet recommended by ACIP, is available for use in accordance with the package insert. Physicians can use the vaccine for adults 50 years of age and older consistent with the package insert.

Back to top


CDC publishes article on a 2011 measles outbreak linked to an arriving refugee in Los Angeles County
CDC published Measles Outbreak Associated with an Arriving Refugee—Los Angeles County, California, August–September 2011 in the June 1 issue of MMWR (pages 385–389). A press summary of the article is reprinted below.

Measles should be suspected in any patient with a fever and a rash who has recently traveled internationally. In August–September 2011, the Los Angeles County Department of Public Health (LACDPH) and California Department of Public Health (CDPH) investigated a measles outbreak associated with an ill unvaccinated refugee traveling from Malaysia to Los Angeles for resettlement in the United States. Health officials identified 3 other measles cases in Los Angeles County among persons who had been exposed to the index patient: 2 unvaccinated infants on the same flight and 1 adult customs worker who did not have proof of measles vaccination. A total of 298 people were interviewed in this large outbreak response. This outbreak emphasizes the importance of ongoing vigilance for measles in the United States, particularly among incoming international travelers, and the importance of vaccinating persons at increased risk of measles exposure.

Back to top


Spotlight on immunize.org: Quick access to ACIP recommendations
Looking for quick access to official recommendations of CDC’s Advisory Committee on Immunization Practices (ACIP)? Look no further. IAC’s ACIP web section provides up-to-date access to ACIP vaccine recommendations, which are listed by date, vaccine, and topic.

Related Links Back to top


VACCINE INFORMATION STATEMENTS

CDC releases a new VIS for typhoid vaccine
On May 29, CDC released a new VIS for typhoid vaccine. CDC made minor changes throughout the VIS. The most significant change is that it is now recommended that healthcare providers wait at least three days before administering live, oral typhoid vaccine to patients who have received certain antibiotics. Previously, healthcare providers were advised to wait 24 hours. Because this change concerns a precaution (see Section 4 of the VIS), CDC recommends that providers start using the new VIS immediately when planning to administer typhoid vaccine.
Back to top


IAC posts translations of the hepatitis B vaccine VIS in Armenian, Farsi, Hmong, Korean, and Tagalog
IAC recently posted translations of the hepatitis B vaccine VIS in Armenian, Farsi (spoken in Iran and United Arab Emirates), Hmong, Korean, and Tagalog. IAC thanks the California Department of Public Health, Immunization Branch, for the translations.
Back to top


IAC adds 2D bar codes to its translations of VISs for hepatitis A, hepatitis B, and polio vaccines
IAC recently added two-dimensional (2D) bar codes to all its translations of the following VISs.
About bar codes

Currently 2D bar code technology is designed primarily to help immunization providers record required information about the VIS, by allowing them to scan the name and edition date of a VIS into an electronic medical record, immunization information system, or other electronic database. CDC has created a web page with comprehensive information about 2D bar codes.

Starting in April 2012, CDC began adding bar codes to English-language VISs on an incremental basis. As CDC progresses with this project, IAC will add bar codes to its translations. IAC Express will keep readers informed as the bar code project proceeds.

Back to top


OFFICIAL RELEASES AND ANNOUNCEMENTS

CDC publishes "Summary of Notifiable Diseases, United States, 2010"
On June 1, CDC published Summary of Notifiable Diseases, United States, 2010 as an MMWR Report (Vol. 59, No. 53).

Past issues of the annual summary are available on an online index titled MMWR: Summary of Notifiable Diseases. The index comprises annual issues published from 1993 to 2010.

Back to top



FEATURED RESOURCES

CDC's updated web page on current pertussis outbreaks gives healthcare professionals valuable resources
CDC recently updated its web page Pertussis (Whooping Cough): Outbreaks with a multitude of useful resources for healthcare professionals. The web page now includes links to outbreak-related Q&As, examples of recent U.S. pertussis activity, MMWR articles about outbreaks, and authoritative CDC resources.

Back to top


JOURNAL ARTICLES AND NEWSLETTERS

CDC publishes note about a 2012 investigation of a false-positive measles test in Maine
CDC published Notes from the Field: False-Positive Measles Test—Maine, February 2012 in the June 1 issue of MMWR (page 396).

Back to top


CDC publishes erratum to an article on characteristics associated with influenza vaccination of preschoolers
CDC published Errata: Vol. 60, No. 29 and Vol. 59, No. 27 in the June 1 issue of MMWR (page 397). The erratum for Vol. 60, No. 29 concerns an MMWR article related to immunization, Characteristics Associated with Seasonal Influenza Vaccination of Preschool Children—Oregon, 2006–2008. It was published in the MMWR issue dated July 29, 2011 (pages 981–984).

Back to top


EDUCATION AND TRAINING

Save the dates: The Immunization Partnership plans two webinars, one for June 12 and one for July 19
The Immunization Partnership has scheduled the following webinars for summer 2012.
The Immunization Partnership

With a focus on the Houston (TX) area, The Immunization Partnership works to eradicate vaccine-preventable diseases by developing and coordinating community resources through public and private partnerships. The organization has three focus areas: support of immunization information systems, advocacy, and education.

Back to top



About IAC Express 
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue.
If you have trouble receiving or displaying IAC Express messages, visit our online help section.
IAC Express is supported in part by Grant No. U38IP000589 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC. IAC Express is also supported by educational grants from the following companies: Baxter Healthcare Corp.; CSL Biotherapies; GlaxoSmithKline; MedImmune, Inc.; Merck Sharp & Dohme Corp.; Novartis Vaccines; Ortho Clinical Diagnostics, Inc.; Pfizer, Inc.; and sanofi pasteur.
IAC Express Disclaimer
ISSN: 1526-1786

Our mailing address is
Immunization Action Coalition
1573 Selby Ave, Ste 234
St. Paul, MN 55104


Copyright (C) 2012 Immunization Action Coalition
All rights reserved.
Subscribe Today: IAC Express, Needle Tips, and Vaccinate Adults: the up-to-date immunization information you need
IAC Express
IAC Express Home
2014 Issues
2013 Issues
2012 Issues
2011 Issues
2010 - 1997 Issues
Praise for IAC Express
Help
Disclaimer
Video of the Week
Video: Keeping Patients Safe From Infection in Outpatient Settings
Keeping Patients Safe From Infection in Outpatient Settings: In the absence of accreditation, patient safety and infection control is a matter of trust in ambulatory care settings, Dr. Joseph Perz of the CDC explains in this video from Medscape. This 4-min video was recorded at the Society for Healthcare Epidemiology of America (SHEA) Spring Meeting.
Visit the VOTW archive
Issue Abbreviations
AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; AMA, American Medical Association; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD, National Center for Immunization and Respiratory Diseases; NIVS, National Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
Publication Staff
Editor: Deborah L. Wexler, MD
Managing Editor: Dale Thompson, MA
Associate Editor: Teresa Anderson, DDS, MPH
Editorial Assistant: Janelle Tangonan Anderson
Additional Information
News & Information
Media coverage about vaccines and vaccine-preventable diseases
Calendar of Events
Conferences and meetings on immunization
Shop IAC
Record cards, laminated schedules and more
 
This page was reviewed on June 5, 2012
 
Immunization Action Coalition  •  1573 Selby Ave  •  St. Paul, MN 55104
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.